Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Business

FILE PHOTO: Exact Sciences Laboratories building is shown in Madison, Wisconsin, U.S., March 28, 2019. REUTERS/Howard Schneider

(Reuters) – Cancer diagnostics company Exact Sciences Corp (EXAS.O) is in advanced negotiations to buy healthcare company Genomic Health Inc (GHDX.O) for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

A deal could be announced as early as next week but the talks could still be delayed or fall apart altogether, according to the report, which cited people familiar with the matter.

Exact Sciences and Genomic Health did not respond immediately to a Reuters request for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; Editing by Sonya Hepinstall

Products You May Like

Articles You May Like

Crunch talks between RMT and Network Rail begin as union threatens further strikes
Gunman suspected of killing six at Fourth of July parade in Chicago arrested
British Airways cancels 11% of flights in summer holiday peak
Book Riot’s Deals of the Day for June 30, 2022
Why Victoria Beckham Is Concerned for Daughter Harper to Join “Quite Terrifying” Social Media

Leave a Reply

Your email address will not be published.